Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017)
Intellia Therapeutics' (NTLA) quarterly Depreciation and Depletion came in at $660000.0 in Q1 2017, up 252.94% year-on-year from $187000.0 in Q1 2016, and up 64.59% on a QoQ basis from $401000.0 in Q4 2016.
Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017) Analysis & Trends
Intellia Therapeutics (NTLA) has 3 years of Depreciation and Depletion data on file, last reported at $660000.0 in Q1 2017.
- On a quarterly basis, Depreciation and Depletion rose 252.94% year-over-year to $660000.0 in Q1 2017; TTM through Mar 2017 was $1.6 million, a 246.48% increase from a year earlier, with the FY2017 full-year figure at $3.0 million, up 172.73% from the prior year.
- Depreciation and Depletion for Q1 2017 stood at $660000.0, up from $401000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for NTLA reached as high as $660000.0 in Q1 2017 and fell as low as $33000.0 in Q1 2015.
- Historically, Depreciation and Depletion has averaged $228888.9 across 3 years, with a median of $187000.0 in 2016.
- On a YoY basis, Depreciation and Depletion climbed as much as 466.67% in 2016 and fell as far as 176.04% in 2016.
- Year by year, Depreciation and Depletion stood at $104000.0 in 2015, then jumped by 285.58% to $401000.0 in 2016, then surged by 64.59% to $660000.0 in 2017.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $660000.0 in Q1 2017, $401000.0 in Q4 2016, and $265000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Intellia Therapeutics | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 660,000.00 |
| Mar 31, 2017 | 660,000.00 |
| Dec 31, 2016 | 401,000.00 |
| Dec 31, 2016 | 401,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Jun 30, 2016 | 247,000.00 |
| Jun 30, 2016 | 247,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Dec 31, 2015 | 104,000.00 |
| Dec 31, 2015 | 104,000.00 |
| Sep 30, 2015 | 96,000.00 |
| Sep 30, 2015 | 96,000.00 |
| Jun 30, 2015 | 67,000.00 |
| Jun 30, 2015 | 67,000.00 |
| Mar 31, 2015 | 33,000.00 |
| Mar 31, 2015 | 33,000.00 |